Pure Global
NCT06012058

Glaucoma Screening With Artificial Intelligence

Glaucoma Screening With Artificial Intelligence - A Randomized Clinical Trial Comparing Retinal Nerve Fiber Layer Optical Texture Analysis and Optic Disc Photography Assessment
The University of Hong Kong·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Drug/Device/Intervention
ROTA assessment by AI
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
The University of Hong Kong
Location
Aberdeen,Kwun Tong, China
Timeline & enrollment
Phase
N/A
Start date
Aug 26, 2023
End date
Feb 25, 2025
Enrollment
3175 participants
Primary outcome

Diagnostic performance for detection of glaucoma

Summary

This randomized clinical trial aims to compare the diagnostic performance of two AI-enabled
 screening strategies - ROTA (RNFL optical texture analysis) assessment versus optic disc
 photography - in detecting glaucoma within a population-based sample. Secondary objectives
 are to (1) compare the diagnostic performance of ROTA AI assessment versus OCT RNFL thickness
 assessment by AI, and ROTA AI assessment versus OCT RNFL thickness assessment by trained
 graders, (2) investigate the cost-effectiveness of AI ROTA assessment for glaucoma screening,
 and (3) estimate the prevalence of glaucoma in Hong Kong.

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06012058
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06012058 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Hong Kong and is currently Recruiting. The study focuses on Glaucoma. Target enrollment is 3175 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.